IR-News

AUSSENDER



Marinomed Biotech AG
Ansprechpartner: Pascal Schmidt, CFO
Tel.: +43 2262 90300
E-Mail: pascal.schmidt@marinomed.com
pta20220128014
Change of total number of voting rights and capital according to article 135 section 1 BörseG

Marinomed Biotech AG: Change of total number of voting rights and capital according to article 135 section 1 BörseG


Korneuburg (pta014/28.01.2022/11:00) - Marinomed Biotech AG hereby announces that due to the exercise of the convertible bond with Nice & Green as well as the further exercise of stock options from the current employee stock option plan the total number of voting rights at the end of January 2022 has increased to 1,484,706 and the new stated capital amounts to EUR 1,484,706. The change of total voting rights has been effective since January 24, 2022.

(end)
emitter: Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg
Austria
contact person: Pascal Schmidt, CFO
phone: +43 2262 90300
e-mail: pascal.schmidt@marinomed.com
website: www.marinomed.com
stock exchanges: official trade in Vienna
ISIN(s): ATMARINOMED6 (share)
|
|
98.756 Abonnenten
|
203.035 Meldungen
|
83.888 Pressefotos

BUSINESS

23.09.2022 - 12:05 | Pressestelle Salzburg Wohnbau c/o JAGER PR
23.09.2022 - 06:15 | pressetext.redaktion
22.09.2022 - 15:00 | Financial Planning Standards Board Deutschland e.V.
22.09.2022 - 14:50 | Photovoltaic Austria Bundesverband
22.09.2022 - 14:15 | SRH AlsterResearch AG
Top